Your search resulted in multiple matches. Please select a position:

Gencode Genes

FOXM1 (ENST00000342628.6) at chr12:2857683-2876986 - Homo sapiens forkhead box M1 (FOXM1), transcript variant 1, mRNA. (from RefSeq NM_202002)
FOXM1 (ENST00000627656.2) at chr12:2857681-2877155 - Homo sapiens forkhead box M1 (FOXM1), transcript variant 4, mRNA. (from RefSeq NM_001243088)
FOXM1 (ENST00000545049.1) at chr12:2868231-2874200 - forkhead box M1 (from HGNC FOXM1)
FOXM1 (ENST00000538564.5) at chr12:2864432-2874214 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt H0YGS4)
FOXM1 (ENST00000537018.5) at chr12:2864885-2874137 - forkhead box M1 (from HGNC FOXM1)
FOXM1 (ENST00000536066.1) at chr12:2857681-2864854 - forkhead box M1 (from HGNC FOXM1)
FOXM1 (ENST00000535350.1) at chr12:2859488-2868581 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt H0YG99)
FOXM1 (ENST00000366362.3) at chr12:2863749-2864710 - forkhead box M1 (from HGNC FOXM1)
FOXM1 (ENST00000361953.7) at chr12:2857683-2877040 - Homo sapiens forkhead box M1 (FOXM1), transcript variant 3, mRNA. (from RefSeq NM_202003)
FOXM1 (ENST00000359843.7) at chr12:2857684-2876941 - Homo sapiens forkhead box M1 (FOXM1), transcript variant 2, mRNA. (from RefSeq NM_021953)
FRGCA (ENST00000424933.1) at chr21:43140523-43141092 - Homo sapiens FOXM1-regulated, gastric cancer associated-like (LOC106780825), long non-coding RNA. (from RefSeq NR_133678)
CHEK2 (ENST00000650281.1) at chr22:28687766-28741806 - Serine/threonine-protein kinase which is required for  checkpoint-mediated cell cycle arrest, activation of DNA repair  and apoptosis in response to the presence of DNA double-strand  breaks. May also negatively regulate cell cycle progression during  unperturbed cell cycles. Following activation, phosphorylates  numerous effectors preferentially at the consensus sequence [L-X-  R-X-X-S/T]. Regulates cell cycle checkpoint arrest through  phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their  activity. Inhibition of CDC25 phosphatase activity leads to  increased inhibitory tyrosine phosphorylation of CDK-cyclin  complexes and blocks cell cycle progression. May also  phosphorylate NEK6 which is involved in G2/M cell cycle arrest.  Regulates DNA repair through phosphorylation of BRCA2, enhancing  the association of RAD51 with chromatin which promotes DNA repair  by homologous recombination. Also stimulates the transcription of  genes involved in DNA repair (including BRCA2) through the  phosphorylation and activation of the transcription factor FOXM1.  Regulates apoptosis through the phosphorylation of p53/TP53, MDM4  and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may  alleviate inhibition by MDM2, leading to accumulation of active  p53/TP53. Phosphorylation of MDM4 may also reduce degradation of  p53/TP53. Also controls the transcription of pro-apoptotic genes  through phosphorylation of the transcription factor E2F1. Tumor  suppressor, it may also have a DNA damage-independent function in  mitotic spindle assembly by phosphorylating BRCA1. Its absence may  be a cause of the chromosomal instability observed in some cancer  cells. (from UniProt O96017)
CHEK2 (ENST00000448511.5) at chr22:28687887-28734721 - Serine/threonine-protein kinase which is required for  checkpoint-mediated cell cycle arrest, activation of DNA repair  and apoptosis in response to the presence of DNA double-strand  breaks. May also negatively regulate cell cycle progression during  unperturbed cell cycles. Following activation, phosphorylates  numerous effectors preferentially at the consensus sequence [L-X-  R-X-X-S/T]. Regulates cell cycle checkpoint arrest through  phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their  activity. Inhibition of CDC25 phosphatase activity leads to  increased inhibitory tyrosine phosphorylation of CDK-cyclin  complexes and blocks cell cycle progression. May also  phosphorylate NEK6 which is involved in G2/M cell cycle arrest.  Regulates DNA repair through phosphorylation of BRCA2, enhancing  the association of RAD51 with chromatin which promotes DNA repair  by homologous recombination. Also stimulates the transcription of  genes involved in DNA repair (including BRCA2) through the  phosphorylation and activation of the transcription factor FOXM1.  Regulates apoptosis through the phosphorylation of p53/TP53, MDM4  and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may  alleviate inhibition by MDM2, leading to accumulation of active  p53/TP53. Phosphorylation of MDM4 may also reduce degradation of  p53/TP53. Also controls the transcription of pro-apoptotic genes  through phosphorylation of the transcription factor E2F1. Tumor  suppressor, it may also have a DNA damage-independent function in  mitotic spindle assembly by phosphorylating BRCA1. Its absence may  be a cause of the chromosomal instability observed in some cancer  cells. (from UniProt O96017)
CHEK2 (ENST00000433728.5) at chr22:28687887-28734721 - Serine/threonine-protein kinase which is required for  checkpoint-mediated cell cycle arrest, activation of DNA repair  and apoptosis in response to the presence of DNA double-strand  breaks. May also negatively regulate cell cycle progression during  unperturbed cell cycles. Following activation, phosphorylates  numerous effectors preferentially at the consensus sequence [L-X-  R-X-X-S/T]. Regulates cell cycle checkpoint arrest through  phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their  activity. Inhibition of CDC25 phosphatase activity leads to  increased inhibitory tyrosine phosphorylation of CDK-cyclin  complexes and blocks cell cycle progression. May also  phosphorylate NEK6 which is involved in G2/M cell cycle arrest.  Regulates DNA repair through phosphorylation of BRCA2, enhancing  the association of RAD51 with chromatin which promotes DNA repair  by homologous recombination. Also stimulates the transcription of  genes involved in DNA repair (including BRCA2) through the  phosphorylation and activation of the transcription factor FOXM1.  Regulates apoptosis through the phosphorylation of p53/TP53, MDM4  and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may  alleviate inhibition by MDM2, leading to accumulation of active  p53/TP53. Phosphorylation of MDM4 may also reduce degradation of  p53/TP53. Also controls the transcription of pro-apoptotic genes  through phosphorylation of the transcription factor E2F1. Tumor  suppressor, it may also have a DNA damage-independent function in  mitotic spindle assembly by phosphorylating BRCA1. Its absence may  be a cause of the chromosomal instability observed in some cancer  cells. (from UniProt O96017)
CHEK2 (ENST00000417588.5) at chr22:28687887-28734721 - Serine/threonine-protein kinase which is required for  checkpoint-mediated cell cycle arrest, activation of DNA repair  and apoptosis in response to the presence of DNA double-strand  breaks. May also negatively regulate cell cycle progression during  unperturbed cell cycles. Following activation, phosphorylates  numerous effectors preferentially at the consensus sequence [L-X-  R-X-X-S/T]. Regulates cell cycle checkpoint arrest through  phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their  activity. Inhibition of CDC25 phosphatase activity leads to  increased inhibitory tyrosine phosphorylation of CDK-cyclin  complexes and blocks cell cycle progression. May also  phosphorylate NEK6 which is involved in G2/M cell cycle arrest.  Regulates DNA repair through phosphorylation of BRCA2, enhancing  the association of RAD51 with chromatin which promotes DNA repair  by homologous recombination. Also stimulates the transcription of  genes involved in DNA repair (including BRCA2) through the  phosphorylation and activation of the transcription factor FOXM1.  Regulates apoptosis through the phosphorylation of p53/TP53, MDM4  and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may  alleviate inhibition by MDM2, leading to accumulation of active  p53/TP53. Phosphorylation of MDM4 may also reduce degradation of  p53/TP53. Also controls the transcription of pro-apoptotic genes  through phosphorylation of the transcription factor E2F1. Tumor  suppressor, it may also have a DNA damage-independent function in  mitotic spindle assembly by phosphorylating BRCA1. Its absence may  be a cause of the chromosomal instability observed in some cancer  cells. (from UniProt O96017)
CHEK2 (ENST00000405598.5) at chr22:28687762-28741800 - Serine/threonine-protein kinase which is required for  checkpoint-mediated cell cycle arrest, activation of DNA repair  and apoptosis in response to the presence of DNA double-strand  breaks. May also negatively regulate cell cycle progression during  unperturbed cell cycles. Following activation, phosphorylates  numerous effectors preferentially at the consensus sequence [L-X-  R-X-X-S/T]. Regulates cell cycle checkpoint arrest through  phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their  activity. Inhibition of CDC25 phosphatase activity leads to  increased inhibitory tyrosine phosphorylation of CDK-cyclin  complexes and blocks cell cycle progression. May also  phosphorylate NEK6 which is involved in G2/M cell cycle arrest.  Regulates DNA repair through phosphorylation of BRCA2, enhancing  the association of RAD51 with chromatin which promotes DNA repair  by homologous recombination. Also stimulates the transcription of  genes involved in DNA repair (including BRCA2) through the  phosphorylation and activation of the transcription factor FOXM1.  Regulates apoptosis through the phosphorylation of p53/TP53, MDM4  and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may  alleviate inhibition by MDM2, leading to accumulation of active  p53/TP53. Phosphorylation of MDM4 may also reduce degradation of  p53/TP53. Also controls the transcription of pro-apoptotic genes  through phosphorylation of the transcription factor E2F1. Tumor  suppressor, it may also have a DNA damage-independent function in  mitotic spindle assembly by phosphorylating BRCA1. Its absence may  be a cause of the chromosomal instability observed in some cancer  cells. (from UniProt O96017)
CHEK2 (ENST00000403642.5) at chr22:28687897-28734721 - Serine/threonine-protein kinase which is required for  checkpoint-mediated cell cycle arrest, activation of DNA repair  and apoptosis in response to the presence of DNA double-strand  breaks. May also negatively regulate cell cycle progression during  unperturbed cell cycles. Following activation, phosphorylates  numerous effectors preferentially at the consensus sequence [L-X-  R-X-X-S/T]. Regulates cell cycle checkpoint arrest through  phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their  activity. Inhibition of CDC25 phosphatase activity leads to  increased inhibitory tyrosine phosphorylation of CDK-cyclin  complexes and blocks cell cycle progression. May also  phosphorylate NEK6 which is involved in G2/M cell cycle arrest.  Regulates DNA repair through phosphorylation of BRCA2, enhancing  the association of RAD51 with chromatin which promotes DNA repair  by homologous recombination. Also stimulates the transcription of  genes involved in DNA repair (including BRCA2) through the  phosphorylation and activation of the transcription factor FOXM1.  Regulates apoptosis through the phosphorylation of p53/TP53, MDM4  and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may  alleviate inhibition by MDM2, leading to accumulation of active  p53/TP53. Phosphorylation of MDM4 may also reduce degradation of  p53/TP53. Also controls the transcription of pro-apoptotic genes  through phosphorylation of the transcription factor E2F1. Tumor  suppressor, it may also have a DNA damage-independent function in  mitotic spindle assembly by phosphorylating BRCA1. Its absence may  be a cause of the chromosomal instability observed in some cancer  cells. (from UniProt O96017)
CHEK2 (ENST00000402731.5) at chr22:28687897-28734721 - Serine/threonine-protein kinase which is required for  checkpoint-mediated cell cycle arrest, activation of DNA repair  and apoptosis in response to the presence of DNA double-strand  breaks. May also negatively regulate cell cycle progression during  unperturbed cell cycles. Following activation, phosphorylates  numerous effectors preferentially at the consensus sequence [L-X-  R-X-X-S/T]. Regulates cell cycle checkpoint arrest through  phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their  activity. Inhibition of CDC25 phosphatase activity leads to  increased inhibitory tyrosine phosphorylation of CDK-cyclin  complexes and blocks cell cycle progression. May also  phosphorylate NEK6 which is involved in G2/M cell cycle arrest.  Regulates DNA repair through phosphorylation of BRCA2, enhancing  the association of RAD51 with chromatin which promotes DNA repair  by homologous recombination. Also stimulates the transcription of  genes involved in DNA repair (including BRCA2) through the  phosphorylation and activation of the transcription factor FOXM1.  Regulates apoptosis through the phosphorylation of p53/TP53, MDM4  and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may  alleviate inhibition by MDM2, leading to accumulation of active  p53/TP53. Phosphorylation of MDM4 may also reduce degradation of  p53/TP53. Also controls the transcription of pro-apoptotic genes  through phosphorylation of the transcription factor E2F1. Tumor  suppressor, it may also have a DNA damage-independent function in  mitotic spindle assembly by phosphorylating BRCA1. Its absence may  be a cause of the chromosomal instability observed in some cancer  cells. (from UniProt O96017)
FOXO3 (ENST00000540898.1) at chr6:108656346-108680751 - Transcriptional activator which triggers apoptosis in  the absence of survival factors, including neuronal cell death  upon oxidative stress. Recognizes and binds to the DNA sequence  5'-[AG]TAAA[TC]A-3'. Participates in post-transcriptional  regulation of MYC: following phosphorylation by MAPKAPK5, promotes  induction of miR-34b and miR-34c expression, 2 post-  transcriptional regulators of MYC that bind to the 3'UTR of MYC  transcript and prevent its translation. (from UniProt O43524)
FOXO3 (ENST00000343882.10) at chr6:108559835-108684774 - Homo sapiens forkhead box O3 (FOXO3), transcript variant 2, mRNA. (from RefSeq NM_201559)
FOXO3 (ENST00000406360.2) at chr6:108560917-108684774 - Homo sapiens forkhead box O3 (FOXO3), transcript variant 1, mRNA. (from RefSeq NM_001455)
PLK1 (ENST00000300093.9) at chr16:23678889-23690367 - Homo sapiens polo like kinase 1 (PLK1), mRNA. (from RefSeq NM_005030)
CHEK2 (ENST00000649563.1) at chr22:28687751-28741806 - Homo sapiens checkpoint kinase 2 (CHEK2), transcript variant 4, mRNA. (from RefSeq NM_001257387)
CHEK2 (ENST00000348295.7) at chr22:28687743-28741834 - Homo sapiens checkpoint kinase 2 (CHEK2), transcript variant 2, mRNA. (from RefSeq NM_145862)
CHEK2 (ENST00000404276.6) at chr22:28687743-28741820 - Homo sapiens checkpoint kinase 2 (CHEK2), transcript variant 1, mRNA. (from RefSeq NM_007194)
CHEK2 (ENST00000382580.6) at chr22:28687763-28741838 - Homo sapiens checkpoint kinase 2 (CHEK2), transcript variant 3, mRNA. (from RefSeq NM_001005735)
CDK6 (ENST00000265734.8) at chr7:92604921-92833917 - Homo sapiens cyclin dependent kinase 6 (CDK6), transcript variant 1, mRNA. (from RefSeq NM_001259)
CDK6 (ENST00000424848.2) at chr7:92615140-92836594 - Homo sapiens cyclin dependent kinase 6 (CDK6), transcript variant 2, mRNA. (from RefSeq NM_001145306)
CTNNB1 (ENST00000647390.1) at chr3:41199486-41239900 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000646725.1) at chr3:41199636-41239950 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000646369.1) at chr3:41199713-41239912 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000645982.1) at chr3:41199442-41239955 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000645210.1) at chr3:41194848-41239970 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000644867.1) at chr3:41199621-41239913 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000643992.1) at chr3:41199479-41239900 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000643977.1) at chr3:41199736-41239900 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000643297.1) at chr3:41200111-41239960 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000643031.1) at chr3:41199434-41240445 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000642426.1) at chr3:41199505-41239954 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000642315.1) at chr3:41200143-41239904 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000642248.1) at chr3:41194893-41239900 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000450969.6) at chr3:41200112-41239906 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000441708.2) at chr3:41220954-41239767 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000431914.6) at chr3:41198679-41239899 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000405570.6) at chr3:41194868-41239904 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000645320.1) at chr3:41220551-41239888 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000642992.1) at chr3:41198645-41239945 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000433400.6) at chr3:41194994-41239971 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000643541.1) at chr3:41194741-41239949 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000396185.8) at chr3:41199389-41240443 - Key downstream component of the canonical Wnt signaling  pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2,  APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal  Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its  subsequent degradation by the proteasome. In the presence of Wnt  ligand, CTNNB1 is not ubiquitinated and accumulates in the  nucleus, where it acts as a coactivator for transcription factors  of the TCF/LEF family, leading to activate Wnt responsive genes.  Involved in the regulation of cell adhesion. Acts as a negative  regulator of centrosome cohesion. Involved in the  CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization.  Blocks anoikis of malignant kidney and intestinal epithelial cells  and promotes their anchorage-independent growth by down-regulating  DAPK2. (from UniProt P35222)
CTNNB1 (ENST00000396183.7) at chr3:41199434-41240443 - Homo sapiens catenin beta 1 (CTNNB1), transcript variant 3, mRNA. (from RefSeq NM_001098210)
CTNNB1 (ENST00000349496.11) at chr3:41199505-41240443 - Homo sapiens catenin beta 1 (CTNNB1), transcript variant 1, mRNA. (from RefSeq NM_001904)

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

NM_202002.2 at chr12:2857681-2877155
NM_021953.3 at chr12:2857681-2877155
NM_202003.2 at chr12:2857681-2877155
NM_001243088.1 at chr12:2857681-2877155
NM_001243089.1 at chr12:2857681-2877155

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

XM_011520934.3 at chr12:2857680-2877155
XM_005253676.4 at chr12:2857680-2877155
XM_011520931.3 at chr12:2857680-2877155
XM_011520930.3 at chr12:2857680-2877155
XR_931507.1 at chr12:2859574-2877155
XM_011520932.1 at chr12:2859574-2877155
XM_011520933.1 at chr12:2859574-2877155
XM_011520935.1 at chr12:2859574-2877155

RefSeq Genes

FOXM1 at chr12:2857680-2877174 - (NM_202003) forkhead box protein M1 isoform 3
FOXM1 at chr12:2857680-2877174 - (NM_202002) forkhead box protein M1 isoform 1
FOXM1 at chr12:2857680-2877174 - (NM_001243089) forkhead box protein M1 isoform 5
FOXM1 at chr12:2857681-2877155 - (NM_001243088) forkhead box protein M1 isoform 4
FOXM1 at chr12:2857680-2877174 - (NM_021953) forkhead box protein M1 isoform 2

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

FOXM1-regulated, gastric cancer associated at chr21:43140523-43141092 - (NR_133677.1)
FOXM1-regulated, gastric cancer associated-like at chr21:6532207-6532776 - (NR_133678.1)

Non-Human RefSeq Genes

FOXM1 at chr12:2858636-2874508 - (NM_001314325) forkhead box protein M1
foxm1 at chr12:2858638-2868709 - (NM_001160463) forkhead box protein M1
FOXM1 at chr12:2858677-2874516 - (NM_001012955) forkhead box protein M1
Foxm1 at chr12:2857748-2874527 - (NM_031633) forkhead box protein M1
foxm1 at chr12:2858638-2874307 - (NM_201097) forkhead box protein M1
Foxm1 at chr12:2856771-2874527 - (NM_008021) forkhead box protein M1

Basic Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Basic Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Basic Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Basic Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Basic Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Basic Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Basic Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Basic Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Basic Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857681-2877155
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Basic Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941

Comprehensive Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

FOXM1 at chr12:2857681-2864854
FOXM1 at chr12:2857683-2876986
FOXM1 at chr12:2857683-2877040
FOXM1 at chr12:2857684-2876941
FOXM1 at chr12:2859488-2868581
FOXM1 at chr12:2863749-2864710
FOXM1 at chr12:2864432-2874214
FOXM1 at chr12:2864885-2874137
FOXM1 at chr12:2868231-2874200

Retroposed Genes V9, Including Pseudogenes

FOXM1_HUMAN at chr7:149744396-149747217 - (NM_202002.2-20)
FOXM1 at chr7:149744396-149747217 - (NM_202002.2-20)
FOXM1 at chr7:149744396-149747217 - (NM_202002.2-20)

International Knockout Mouse Consortium Genes Mapped to Human Genome

Foxm1_32887 at chr12:2857683-2877137
Foxm1_32888 at chr12:2857683-2877137
Foxm1_83022 at chr12:2857683-2877137
Foxm1_VG19640 at chr12:2857683-2877137

Human Aligned mRNA Search Results

LT978477 - Homo sapiens mRNA for FOXM1C (FOXM1 gene).
LT978476 - Homo sapiens mRNA for FOXM1B (FOXM1 gene).
LT978475 - Homo sapiens mRNA for FOXM1A (FOXM1 gene).
LT978478 - Homo sapiens mRNA for FOXM1A (FOXM1 gene).
LT978474 - Homo sapiens mRNA for a novel forkhead box M1 isoform FOXM1D (FOXM1 gene).
U74613 - Homo sapiens forkhead box M1B (FOXM1B) mRNA, complete cds.
U74612 - Homo sapiens forkhead box M1A (FOXM1A) mRNA, complete cds.
BC006192 - Homo sapiens forkhead box M1, mRNA (cDNA clone MGC:10704 IMAGE:3833837), complete cds.
BC006529 - Homo sapiens forkhead box M1, mRNA (cDNA clone MGC:10705 IMAGE:3834244), complete cds.
BC012863 - Homo sapiens forkhead box M1, mRNA (cDNA clone MGC:9577 IMAGE:3881055), complete cds.
MG600229 - Homo sapiens forkhead box M1-D (FOXM1) mRNA, complete cds, alternatively spliced.
AK291206 - Homo sapiens cDNA FLJ77127 complete cds, highly similar to Homo sapiens forkhead box M1 (FOXM1), transcript variant 3, mRNA.

Human Unaligned mRNA Search Results

NR_133678 - Homo sapiens FOXM1-regulated, gastric cancer associated-like (LOC106780825), long non-coding RNA.
NR_133677 - Homo sapiens FOXM1-regulated, gastric cancer associated (FRGCA), long non-coding RNA.

Non-Human Aligned mRNA Search Results

BC169940 - Xenopus laevis forkhead box protein M1, mRNA (cDNA clone MGC:196667 IMAGE:9041574), complete cds.
KY421022 - Andrias davidianus foxm1 mRNA, complete cds.
MH779618 - Bos taurus FOXM1 mRNA, partial cds.
BC006788 - Mus musculus forkhead box M1, mRNA (cDNA clone IMAGE:3589714), complete cds.
BC054560 - Danio rerio forkhead box M1-like, mRNA (cDNA clone MGC:63854 IMAGE:6788900), complete cds.
KP056826 - Capra hircus forkhead box M1 (FOXM1) mRNA, complete cds.
AY888897 - Synthetic construct Homo sapiens clone FLH110611.01X forkhead box M1 (FOXM1) mRNA, complete cds.
AY888898 - Synthetic construct Homo sapiens clone FLH110612.01X forkhead box M1 (FOXM1) mRNA, complete cds.
AY891511 - Synthetic construct Homo sapiens clone FLH110609.01L forkhead box M1 (FOXM1) mRNA, partial cds.
JU472089 - TSA: Macaca mulatta Mamu_373465 mRNA sequence.
JU474797 - TSA: Macaca mulatta Mamu_373463 mRNA sequence.
JN817622 - UNVERIFIED: Oryctolagus cuniculus forkhead box M1-like (Foxm1) mRNA, complete sequence.
BC065067 - Mus musculus forkhead box M1, mRNA (cDNA clone MGC:86019 IMAGE:6417437), complete cds.
BC075723 - Mus musculus forkhead box M1, mRNA (cDNA clone MGC:78195 IMAGE:6515008), complete cds.